Seamaty: Advancing Point-of-Care Diagnostics with Compact and Automated Solutions

About Seamaty

As healthcare continues to move closer to the patient, point-of-care testing is becoming an increasingly important part of modern diagnostic workflows. Fast access to reliable laboratory information can support clinical decision-making in hospitals, clinics, laboratories, emergency departments, and other healthcare settings.

Seamaty is a medical diagnostics technology company focused on developing compact, automated, and user-friendly diagnostic solutions for point-of-care and decentralized testing.

1、A Broad Portfolio for Modern Medical Diagnostics

Seamaty's medical diagnostic portfolio covers several major testing areas, including clinical chemistry, hematology, blood gas and electrolyte analysis, immunoassay, and integrated point-of-care testing.

The portfolio includes solutions such as the SA1 AI Hematology Morphology Analyzer, SD1080 Fully Automated Microfluidic Dry Chemistry Analyzer, SG1 Blood Gas & Electrolyte Analyzer, SC200 Fully Automated Chemiluminescence Immunoassay Analyzer, SD3 Fully Automated Dry Chemistry Analyzer, SD1 Dry Chemistry Analyzer, SE1 Electrolyte Analyzer, and SMT series chemistry and hematology analyzers.

These systems are designed to address different testing requirements, from routine blood chemistry and hematology to more specialized diagnostic applications.

2、Simplifying Point-of-Care Testing

One of the key considerations in decentralized diagnostics is workflow simplicity. Traditional laboratory testing may involve multiple instruments, liquid reagents, complex preparation procedures, and dedicated laboratory infrastructure.

Seamaty's diagnostic platforms are developed with a focus on simplifying testing workflows through compact instrument designs, automation, integrated testing components, and single-use or simplified reagent formats where applicable.

For example, Seamaty's dry chemistry systems use reagent disc technology to integrate key testing components into a convenient format. This approach can help reduce operational complexity and make diagnostic testing more accessible in smaller laboratories and point-of-care environments.

3、Solutions Across Multiple Testing Areas

● Clinical Chemistry

Seamaty's chemistry analyzers provide solutions for routine biochemical testing and decentralized laboratory applications. Systems such as the SD1, SD3, SD1080 and SMT series are designed for different levels of testing capacity and workflow requirements.

● Hematology

The Seamaty hematology portfolio includes 3-part and 5-part hematology analyzers as well as AI-assisted morphology analysis. The SA1 AI Hematology Morphology Analyzer combines automated hematology testing with AI-based cell recognition and digital imaging technology.

● Blood Gas and Electrolytes

The SG1 Blood Gas & Electrolyte Analyzer provides a portable solution for blood gas and electrolyte testing at the point of care. Its compact design is intended to support rapid testing where immediate diagnostic information is required.

● Immunoassay

The SC200 Fully Automated Chemiluminescence Immunoassay Analyzer combines chemiluminescence technology with a microfluidic platform to provide automated immunoassay testing in point-of-care environments.

● Integrated Diagnostic Workflows

For healthcare facilities looking to consolidate multiple testing capabilities, Seamaty's product portfolio also includes platforms designed to combine different diagnostic technologies within compact systems.

This broader portfolio allows healthcare providers and distributors to select diagnostic solutions according to their testing volume, application, infrastructure, and workflow requirements.

4、Designed for Decentralized Healthcare

Point-of-care testing is particularly valuable when laboratory infrastructure is limited or when rapid access to diagnostic information is important.

Compact analyzers can be deployed in a variety of settings, including:
• Hospitals and hospital departments
• Primary healthcare facilities
• Clinics
• Small and medium-sized laboratories
• Emergency and critical-care environments
• Decentralized testing locations

By combining compact instrument design with automated testing technologies, Seamaty aims to make professional diagnostic testing more accessible beyond the traditional central laboratory.

5、From Instruments to Diagnostic Solutions

Seamaty's approach extends beyond individual analyzers. The company develops diagnostic instruments together with dedicated reagent systems and testing workflows.

This integrated approach is intended to provide a more consistent testing experience while simplifying operation and supporting routine diagnostic applications.

With a growing portfolio covering chemistry, hematology, blood gas, electrolytes, immunoassay, and related technologies, Seamaty provides diagnostic options for healthcare organizations seeking compact and flexible testing solutions.

6、Supporting the Future of Point-of-Care Diagnostics

As healthcare systems continue to evolve toward decentralized and patient-centered testing, diagnostic technologies need to combine analytical performance with practical usability.

Seamaty continues to develop medical diagnostic systems with an emphasis on automation, portability, workflow efficiency, and accessible testing.

Its portfolio provides healthcare professionals, laboratories, distributors, and diagnostic partners with multiple options for bringing laboratory testing capabilities closer to the patient.